Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Frequency of clonal remission in acute myeloid leukaemia.
Gale RE, Wheadon H, Goldstone AH, Burnett AK, Linch DC. Gale RE, et al. Among authors: burnett ak. Lancet. 1993 Jan 16;341(8838):138-42. doi: 10.1016/0140-6736(93)90004-z. Lancet. 1993. PMID: 8093744
A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council.
Langabeer SE, Grimwade D, Walker H, Rogers JR, Burnett AK, Goldstone AH, Linch DC. Langabeer SE, et al. Among authors: burnett ak. Br J Haematol. 1998 May;101(2):338-40. doi: 10.1046/j.1365-2141.1998.00686.x. Br J Haematol. 1998. PMID: 9609531 Free article.
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties.
Wheatley K, Burnett AK, Goldstone AH, Gray RG, Hann IM, Harrison CJ, Rees JK, Stevens RF, Walker H. Wheatley K, et al. Among authors: burnett ak. Br J Haematol. 1999 Oct;107(1):69-79. doi: 10.1046/j.1365-2141.1999.01684.x. Br J Haematol. 1999. PMID: 10520026 Free article. Clinical Trial.
EVI1 expression in acute myeloid leukaemia.
Langabeer SE, Rogers JR, Harrison G, Wheatley K, Walker H, Bain BJ, Burnett AK, Goldstone AH, Linch DC, Grimwade D; MRC Adult Leukaemia Working Party. Langabeer SE, et al. Among authors: burnett ak. Br J Haematol. 2001 Jan;112(1):208-11. doi: 10.1046/j.1365-2141.2001.02569.x. Br J Haematol. 2001. PMID: 11167805 Free article.
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.
Kottaridis PD, Gale RE, Frew ME, Harrison G, Langabeer SE, Belton AA, Walker H, Wheatley K, Bowen DT, Burnett AK, Goldstone AH, Linch DC. Kottaridis PD, et al. Among authors: burnett ak. Blood. 2001 Sep 15;98(6):1752-9. doi: 10.1182/blood.v98.6.1752. Blood. 2001. PMID: 11535508 Free article. Clinical Trial.
Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council.
Hann IM, Stevens RF, Goldstone AH, Rees JK, Wheatley K, Gray RG, Burnett AK. Hann IM, et al. Among authors: burnett ak. Blood. 1997 Apr 1;89(7):2311-8. Blood. 1997. PMID: 9116274 Free article. Clinical Trial.
310 results